We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bioactive Glass S53P4 in Mastoid Obliteration Surgery for Chronic Otitis Media and Cerebrospinal Fluid Leakage.
- Authors
Sarin, Jussi; Grénman, Reidar; Aitasalo, Kalle; Pulkkinen, Jaakko
- Abstract
Objectives: We evaluated the results of cases of chronic otitis media treated with mastoid obliteration surgery using bioactive glass S53P4. Methods: Twenty-five patients with chronic otitis media and 1 patient with cerebrospinal fluid leakage without chronic infection were treated with bioactive glass S53P4. Twenty patients had had previous surgery because of chronic otitis media with or without cholesteatoma. A mastoid obliteration was performed with bioactive glass S53P4 granules and a musculoperiosteal flap with or without bone pate. In 2 patients with a bony dehiscence at the middle cranial fossa, a bioactive glass plate was used to support the protruding dura. In addition, in 3 patients, occlusion of a dural fistula was needed The median follow-up period was 34.5 months (range, 1 to 182 months). Results: Excluding the 2 patients with only 1 month of follow-up at our department, 96% of the patients had a dry, safe ear or only intermittent otorrhea. In 92% of the patients, the objective of achieving a smaller or nonexistent cavity was achieved. Conclusions: Bioactive glass S53P4 is a noteworthy material in mastoid obliteration surgery.
- Subjects
FINLAND; MASTOID process surgery; OTITIS media treatment; GLASS; CEREBROSPINAL fluid; CHOLESTEATOMA; HEALTH outcome assessment; TOMOGRAPHY; EAR secretions; TREATMENT effectiveness; DATA analysis software; DESCRIPTIVE statistics
- Publication
Annals of Otology, Rhinology & Laryngology, 2012, Vol 121, Issue 9, p563
- ISSN
0003-4894
- Publication type
Article
- DOI
10.1177/000348941212100901